The 52nd edition of the leading clinical reference on treatment of infectious diseases and anti-infective drug information, spiral-bound and printed in a larger font (approximately 8pt) for ease of use. Helpful in day-to-day practice and as a component of your organization's antimicrobial stewardship program, The Sanford Guide provides valuable guidance in the age of antibiotic resistance. Popular with physicians, pharmacists, physician assistants, nurse practitioners, and other clinicians. Coverage includes: Clinical syndromes (pathogens, bacterial, fungal, mycobacterial, parasitic viral), Anti-infective agents (dosing, pediatric adjustments, renal adjustments, adverse effects, activity, pharmacology, drug-drug interactions), Preventative therapy. What's new in 2022: Numerous changes throughout, with major changes in the following areas: New Drugs - Addition of new COVID-19 drugs, cefiderocol, ibrexafungerp, brincidofovir, cabotegravir, doravirine, and more. New Tables - ECMO Drug Dos 2025-04-175932.87 MB324页
2024-07-17583.3 MB30页4
2024-07-1958544.06 KB160页8
2024-07-19585.35 MB51页11
2024-07-19583.35 MB25页9
2024-07-19582 MB24页4
2024-07-1958589.39 KB42页2
2024-07-19584.61 MB48页24
2024-07-1958284.53 KB17页10
2024-07-1958187.67 KB7页16
2024-07-20582.44 MB8页26
2024-07-2158821 KB42页11
2024-07-21588.73 MB33页25
2024-07-2158715.97 KB4页8
2024-07-215828.75 KB2页1
2024-07-22587.78 MB83页8
2024-07-265813.02 MB57页
2024-07-2658842.5 KB25页
2024-07-265826.93 MB66页
2024-07-26584.03 MB16页
